HCLTECH
17.01.2022 - CITI On Hcltech Maintain Neutral CMP 1337 Target 1385
17.01.2022 - UBS On Hcltech Maintain Sell CMP 1337 Target 925
17.01.2022 - JpMorgan On Hcltech Maintain Overweight CMP 1337 Target 1500
17.01.2022 - Nomura on Hcltech Maintain Buy CMP 1337 Target 1580
17.01.2022 - MS On Hcltech Maintain Buy Equal Weight CMP 1337 Target 1450
17.01.2022 - Cs On Hcltech Maintain Buy Outerperform CMP 1337 Target 1650
CLSA ON HCL TECH : 20.07.2021
• Maintain BUY, Target at Rs 1,180/share
• Second wave affects 1022; Healthy deal wins & pipeline keep hopes alive
• HCL Tech's problems appear transient not structural
• Cut our FY22/FY23 EPS forecasts 2%/1%
MACQUARIE ON HCL TECH : 20.07.2021
• Maintain Outperform, Target at Rs 1,220/share
* Growth to pick up in coming quarters
* Soft start to FY22E, growth to pick up in coming qtrs
* Products and platforms business hit by seasonal weakness
CLSA ON HCL TECH : 17.06.2021
* Maintain BUY, Target at Rs 1,160/share
* Deep dive into HCL's US$1.6bn ER&D business
• ERS growth acceleration could give a 2ppt uplift to FY22 revenue growth
* HCL is positioning itself to play the digital engineering opportunity
* Reiterate BUY on attractive risk-reward
CLSA ON HCL TECH : 17.06.2021
* MAINTAIN BUY TARGET: 1,160
* CLSA maintains Buy call on HCL Tech. It expects co to sustain high growth over next 2-3 years with an increased investment digital engineering capabilities
* Have Been Investing in Building Its Digital Engineering Capabilities
* Digital Engg Investment Should Help Sustain High Growth Over Next 2-3 Yrs
* Adjust FY22/23CL Estimates For Revised INR/USD Assumptions & Wave-2 Impact
